Q&A: Do Competing Cannabis Interests Repackage Opioid Research?

A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”

Q&A
Newsletter

Cronos exits US • Australia’s adult use push • UC Berkeley launches oral history series • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.